ClinConnect ClinConnect Logo
Search / Trial NCT06464770

Optimizing Infection Prophylaxis Prior to Shoulder Surgery

Launched by UNIVERSITY OF WASHINGTON · Jun 12, 2024

Trial Information

Current as of July 13, 2025

Recruiting

Keywords

Periprosthetic Joint Infection Cutibacterium Shoulder Arthroplasty Chlorhexidine

ClinConnect Summary

This clinical trial is studying how to reduce a type of bacteria called C. acnes on the skin before shoulder surgery. The researchers want to find out if applying a skin disinfectant called ChloraPrep with different amounts of pressure affects the level of this bacteria. Participants will have one shoulder cleaned with gentle pressure, like a light wipe, and the other shoulder cleaned with firmer pressure, similar to a massage. By comparing the bacteria levels before and after the cleaning, the researchers hope to see if one method is more effective than the other.

To join this study, participants should be English-speaking men between the ages of 65 and 74. They should not have very sensitive skin, allergies to ChloraPrep, or any recent use of antibiotics or acne treatments. Additionally, participants should not have any wounds on their shoulders. During the study, participants can expect to have some skin samples taken before and after the ChloraPrep application to measure the bacteria levels. This information could help improve infection prevention before shoulder surgeries in the future.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • English speaking
  • Exclusion Criteria:
  • Self report very sensitive skin
  • Allergic to chlorhexidine
  • Used antibiotics in the last three months
  • Used acne treatment in the last three months
  • Wounds on your shoulders

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Jason Hsu, MD

Principal Investigator

University of Washington

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported